Ahrn B, Masmiquel L, Kumar H et al (2017) Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
It has been demonstrated that PINK1 plays a regulatory role in the expression of key fission proteins, including Drp1, Fis1 and fusion protein Mfn2
Healing peptides like BPC-157 and TB-500 are typically run for shorter, focused cycles (4-12 weeks) to address an acute issue
The two products differ only in the intended use
View our lab testing program What is Dihexa's proposed mechanism of action at the HGF/MET receptor pathway
Gameiro, P